About Clinical Trials

Clinical trials are an important part of the development of medical treatments. They are conducted in a series of steps, called phases. Each phase is designed to answer a separate research question so that regulatory authorities—such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe—can decide if an investigational therapy can be approved for the treatment of a disease.

Am I Eligible?

This clinical trial is designed to answer questions about whether or not the investigational therapy is effective for ALS.

Clinical trials are closely monitored and reviewed by regulatory bodies in individual countries to ensure they are being conducted correctly and that the rights of participants are protected.

  • Participation in a clinical trial is always voluntary.
  • You may withdraw at any time and for any reason.
  • If you decide you do not want to participate, it will not affect your care now or in the future.

Starting the Conversation

If you are interested in participating, fill out our online questionnaire to find out if you may be eligible to participate. If you meet the general requirements, you will be given an opportunity to ask the doctor conducting the clinical trial and their staff questions about the clinical trial. You will also be provided with an “Informed Consent Form” that explains the details of the clinical trial. If you and the doctor decide you are eligible to possibly participate, you will be asked to provide your consent by signing the form. This process is called the informed consent process, and it is a standard process of participation in a clinical trial.

Once you have completed the informed consent process, the doctor and their staff will conduct medical tests and assessments to determine if you are eligible to participate.